Members of the American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines are as follows. C. Kent Kwoh, MD, Chair: University of Pittsburgh, Pittsburgh, Pennsylvania; Larry G. Anderson, MD: Rheumatology Associates, Portland, Maine; Jerry M. Greene, MD: VA Medical Center, West Roxbury, Massachusetts; Dorothy A. Johnson, DNSc, FNP: Los Angeles County + University of Southern California Medical Center, Los Angeles; James R. O'Dell, MD: University of Nebraska Medical Center, Omaha; Mark L. Robbins, MD, MPH: Harvard Vanguard Medical Associates, Boston, Massachusetts; W. Neal Roberts, Jr., MD: Medical College of Virginia, Richmond; Robert W. Simms, MD: Boston University Arthritis Center, Boston, Massachusetts; Robert A. Yood, MD: The Fallon Clinic, Worcester, Massachusetts.
Article first published online: 5 FEB 2002
Copyright © 2002 by the American College of Rheumatology
Arthritis & Rheumatism
Volume 46, Issue 2, pages 328–346, February 2002
How to Cite
American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines (2002), Guidelines for the management of rheumatoid arthritis: 2002 Update . Arthritis & Rheumatism, 46: 328–346. doi: 10.1002/art.10148
Dr. Kwoh has been a consultant to Wyeth-Ayerst Laboratories and Immunex (both in 1998) and has served as a member of the advisory boards for Aventis Pharmaceuticals (in 1999) and Pfizer (2001). Dr. Anderson has served as a member of the medical advisory board for Merck & Company. Dr. Greene is a shareholder (not major equity) in Johnson & Johnson and Merck & Company. Dr. O'Dell has served on the speaker's bureaus of Aventis Pharmaceuticals, Pharmacia & Upjohn, and Merck & Company, and has served as a consultant to Amgen, Centocor, Immunex, and Bristol-Myers Squibb. Dr. Roberts has received funding for educational activities and clinical trials from Sanofi, Pfizer, and G. D. Searle & Company (during the 1990s; total funding less than $100,000), but currently receives no industry funding. Dr. Simms has served on the speaker's bureau of Merck & Company and has received grant support from Aventis Pharmaceuticals. Dr. Yood is an investigator of an ongoing research trial of anti–tumor necrosis factor α and interleukin-1 receptor antagonist sponsored by Amgen.
The American College of Rheumatology is an independent, professional, medical and scientific society which does not guarantee, warrant, or endorse any commercial product or service.
- Issue published online: 5 FEB 2002
- Article first published online: 5 FEB 2002
- Manuscript Accepted: 2 NOV 2001
- Manuscript Received: 2 JUL 2001